FEATURED COMPANIES

Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches.

- The report ranks the factors that are responsible to accelerate the market growth of flow cytometry- Market is forecasted for period of seven years from 2013 to 2020, with market revenues for 2 historic years - 2011 and 2012- Identification and analysis of key investment pockets for flow cytometry market
players- Identification of challenges that must be addressed and overcome in the flow cytometry market to achieve fiscal success throughout the market- The report identifies and profiles key market participants that would drive innovation in the flow cytometry market

FEATURED COMPANIES

Flow Cytometry Market will Reach $6.5 Billion Globally by 2020 with Increasing Precision. As per the study, the flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9%. Increasing needs to enhance precisions and produce faster results as well as need for compact devices are compelling the clinical and diagnostic organization to adopt innovative technologies. Though popularity has been gained in the application field of life science industry, the cost of the instrument is impeding the growth. Due to this, many researchers are still reluctant in adopting this technology in their research work. Moreover, advancing technologies that has brought complex instrumentation requires highly skilled personals to operate these instruments. ""Flow cytometry market is in developing phase. Enhancing precision in results and presence of numerous flow cytometry techniques such as multicolor and multi-parameter flow cytometry has acted as a strong foothold, assisting the market growth in majority of the developed economies and foresees high potential in the emerging economies such as Asia Pacific and Africa.

These economies have high demand for better health care techniques at an affordable cost. Increasing aged population who need better healthcare, increase in chronic disease and need for better diagnosis and treatment are few driving factors that are impacting the flow cytometry market"" state AMR analysts Debbie Shields and Rohini Patil.

Immunotyping and signal transduction, for example, have been playing a significant role in medical diagnostics. However, conventional technologies used, have limited the accuracy and impacted the result deliverance time of the diagnosis performed. Improving therapeutic scenario is equally attracting focus on early diagnostic tools. Currently, many cancer types have various treatment options; however, this depends on the time of diagnosis and the stage of the cancer. Flow cytometry has been one of the most prevalent technologies which offer solutions for most of the problems discussed above. Key factors restraining the market include high instrument costs and size, lack of awareness among probable users and need for trained personnel.

Most of the users are not aware of the advanced development in the flow cytometry technology and believe that the instruments are space consuming, complex in use and are of high cost, thus affecting the market growth. The global market for flow cytometry is divided into segments such as products, technology, end users, and applications. Instruments market accounts for the largest share of revenue in the flow cytometry market at present and is expected to remain as the highest revenue generator in 2020. Increase in modularity, accessibility, incorporation of imaging capabilities, availability of wavelengths and targets and size reduction are few of the significant trends in the market assisting in adoption of the instruments by the end users.

On the other hand, reagents market is expected to experience the highest growth rate of CAGR 12% during the analysis period. Primary reason escalating this segment is availability of several types of reagents that find diverse usability depending on specific applications like diagnostics, drug discovery, etc.Two technologies are implemented in flow cytometry based research and diagnosis, namely cell based and bead based technologies. In the present scenario as well as throughout the analysis period, cell based technique is leading the market in terms of revenue generation. However, bead based technique is expected to beat this technology in terms of adoption rate by 2020.

North America accounted for the largest share of revenue i.e. 43.5% of the overall Global flow cytometry market at $1.2 billion in 2011. The region is further expected to attain a market size of $2.8 billion by 2020 growing at a CAGR of 10.1%. The company profile in this includes: Advanced analytical Technologies, Inc., Merck Millipore, Becton, Dickinson & co, Beckman Coulter, eBioscience, Partech, Life technologies corp., Luminex Corp, Amnis Corp., Morphosys AG. The primary strategy employed by key players of the market is products launch which is due to demand for newer, faster, and high through put machines that deliver better results.

Note: Product cover images may vary from those shown

“Flow cytometry market was valued $3000 million in 2012, and is expected to reach a value of $6530 million by 2020, experiencing a CAGR of 30.9%.”

Quick Help:
The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.